Brain metastases rare but deadly as first sign of breast cancer return
An analysis of 5,318 early breast cancer patients found that 2 percent developed brain metastases at first recurrence, with triple-negative ...
An analysis of 5,318 early breast cancer patients found that 2 percent developed brain metastases at first recurrence, with triple-negative ...
A new phase II trial protocol will test whether AGuIX nanoparticles, already shown to be tolerated at 100 mg/kg in ...
The phase III MAVERICK trial found that brain MRI surveillance without prophylactic cranial irradiation improved cognitive failure-free survival and caused ...
A case report documents rapid progression and death in a lung cancer patient with a rare EGFR PACC mutation who ...
A retrospective conference study found that early consolidative cranial stereotactic radiotherapy was associated with better outcomes among selected patients with ...
In a 20-patient retrospective study, higher cerebrospinal fluid almonertinib exposure was associated with better brain-MRI response, while no significant exposure-response ...
In the phase 3 REZILIENT 3 trial, adding zipalertinib to platinum-pemetrexed chemotherapy extended median progression-free survival from 8.5 to 14.5 ...
A three-dimensional framework using ontology-aware tissue representation and training-only counterfactual supervision improved brain-metastasis MRI segmentation in 38 cases from a ...
A randomized phase III trial found better cognitive failure–free survival with brain MRI surveillance alone than with surveillance plus cranial ...
A 20-year population-based study in North Savo found that MRI-confirmed brain-metastasis incidence rose 24% per five-year period after age adjustment, ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine